Barclays’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-14,569
| Closed | -$393K | – | 4506 |
|
|
2024
Q2 | $393K | Sell |
14,569
-22,929
| -61% | -$619K | ﹤0.01% | 2676 |
|
|
2024
Q1 | $686K | Sell |
37,498
-15,263
| -29% | -$279K | ﹤0.01% | 2647 |
|
|
2023
Q4 | $647K | Buy |
52,761
+38,826
| +279% | +$476K | ﹤0.01% | 2860 |
|
|
2023
Q3 | $209K | Sell |
13,935
-649
| -4% | -$9.73K | ﹤0.01% | 3011 |
|
|
2023
Q2 | $474K | Sell |
14,584
-4,417
| -23% | -$144K | ﹤0.01% | 2629 |
|
|
2023
Q1 | $744K | Buy |
19,001
+8,819
| +87% | +$345K | ﹤0.01% | 2347 |
|
|
2022
Q4 | $538K | Buy |
10,182
+8,611
| +548% | +$455K | ﹤0.01% | 2558 |
|
|
2022
Q3 | $71K | Sell |
1,571
-163
| -9% | -$7.37K | ﹤0.01% | 3547 |
|
|
2022
Q2 | $63K | Sell |
1,734
-3,996
| -70% | -$145K | ﹤0.01% | 3649 |
|
|
2022
Q1 | $236K | Sell |
5,730
-35,955
| -86% | -$1.48M | ﹤0.01% | 3216 |
|
|
2021
Q4 | $1.78M | Buy |
41,685
+27,819
| +201% | +$1.19M | ﹤0.01% | 1876 |
|
|
2021
Q3 | $763K | Buy |
13,866
+3,571
| +35% | +$197K | ﹤0.01% | 2390 |
|
|
2021
Q2 | $493K | Sell |
10,295
-17,040
| -62% | -$816K | ﹤0.01% | 2480 |
|
|
2021
Q1 | $1.38M | Sell |
27,335
-13,763
| -33% | -$697K | ﹤0.01% | 2115 |
|
|
2020
Q4 | $2.59M | Buy |
41,098
+28,776
| +234% | +$1.81M | ﹤0.01% | 1426 |
|
|
2020
Q3 | $828K | Sell |
12,322
-5,987
| -33% | -$402K | ﹤0.01% | 2036 |
|
|
2020
Q2 | $767K | Buy |
18,309
+12,968
| +243% | +$543K | ﹤0.01% | 2079 |
|
|
2020
Q1 | $168K | Sell |
5,341
-16,650
| -76% | -$524K | ﹤0.01% | 2624 |
|
|
2019
Q4 | $888K | Buy |
21,991
+16,124
| +275% | +$651K | ﹤0.01% | 2371 |
|
|
2019
Q3 | $191K | Buy |
5,867
+1,380
| +31% | +$44.9K | ﹤0.01% | 3081 |
|
|
2019
Q2 | $217K | Buy |
+4,487
| New | +$217K | ﹤0.01% | 3153 |
|